Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583271 · ClinicalTrials.gov registry record
A Prospective Study of EUS Guided Celiac Block
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 127
- Enrollment target
NCT00583271 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 127 participants.
The verdict
NCT00583271 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.
Interventions
- DRUG triamcinolone
- DRUG 98% dehydrated alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2002-06 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00583271
The ClinicalTrials.gov registry entry for NCT00583271 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which triamcinolone is the first listed.
NCT00583271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00583271 about?
NCT00583271 is a clinical study titled "A Prospective Study of EUS Guided Celiac Block". The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.
What is the current status of trial NCT00583271?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2002-06. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00583271?
The interventions under investigation include: triamcinolone (DRUG), 98% dehydrated alcohol (DRUG).
Who is sponsoring clinical trial NCT00583271?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.